Cargando…

The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages

BACKGROUND: An immunosuppressive tumor microenvironment in ovarian cancer facilitates tumor progression and resistance to immunotherapy. The function of MYB Proto-Oncogene Like 2 (MYBL2) in the tumor microenvironment remains largely unexplored. METHODS: A syngeneic intraovarian mouse model, flow cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Baoyue, Wan, Ting, Zhou, Yun, Huang, Shuting, Yuan, Linjing, Jiang, Yinan, Zheng, Xiaojing, Liu, Pingping, Xiang, Huiling, Ju, Mingxiu, Luo, Rongzhen, Jia, Weihua, Lan, ChunYan, Li, Jundong, Zheng, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590509/ https://www.ncbi.nlm.nih.gov/pubmed/37865750 http://dx.doi.org/10.1186/s12935-023-03079-2

Ejemplares similares

Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner
por: Liu, Pingping, et al.
Publicado: (2023)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer
por: Pan, Baoyue, et al.
Publicado: (2022)

A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer
por: Xiang, Huiling, et al.
Publicado: (2023)

Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers
por: Zheng, Xiaojing, et al.
Publicado: (2023)

Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer
por: Jiang, Yinan, et al.
Publicado: (2021)

A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2
por: Vera, Olga, et al.
Publicado: (2021)

A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer
por: Liu, Qian, et al.
Publicado: (2021)

PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer
por: He, Qiuming, et al.
Publicado: (2023)

Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis
por: Zhang, Kui, et al.
Publicado: (2018)

MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia
por: Clarke, M, et al.
Publicado: (2013)

Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients
por: Jia, Yongxu, et al.
Publicado: (2019)

MYBL2 and ATM suppress replication stress in pluripotent stem cells
por: Blakemore, Daniel, et al.
Publicado: (2021)

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer
por: Yoshikawa, Yuki, et al.
Publicado: (2022)

LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis
por: Mu, Xiangyu, et al.
Publicado: (2022)

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
por: Zhou, Yun, et al.
Publicado: (2016)

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy
por: Heinrichs, Stefan, et al.
Publicado: (2013)

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021)

MYBL2 Gene Polymorphism Is Associated With Acute Lymphoblastic Leukemia Susceptibility in Children
por: Guo, Haixia, et al.
Publicado: (2021)

Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma
por: Zhong, Feiliang, et al.
Publicado: (2022)

Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
por: Scheffel, Thamiris Becker, et al.
Publicado: (2021)

Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating MYBL2
por: Fu, Junqi, et al.
Publicado: (2022)

Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells
por: Lee, Yuri, et al.
Publicado: (2022)

A Mutation in the MYBL2-1 Gene Is Associated with Purple Pigmentation in Brassica oleracea
por: Khusnutdinov, Emil, et al.
Publicado: (2022)

MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4
por: Lin, Jiaxin, et al.
Publicado: (2015)

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021)

Targeting the CCL2-CCR2 axis in depressive disorders
por: Curzytek, Katarzyna, et al.
Publicado: (2021)

MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
por: Zhao, Jun-Zhang, et al.
Publicado: (2022)

MYB/MYBL1::QKI fusion-positive diffuse glioma
por: Suh, Ye Yoon, et al.
Publicado: (2023)

The transcription factor AtGLK1 acts upstream of MYBL2 to genetically regulate sucrose-induced anthocyanin biosynthesis in Arabidopsis
por: Zhao, Dongming, et al.
Publicado: (2021)

Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming
por: Ward, Carl, et al.
Publicado: (2018)

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
por: Qin, Hui, et al.
Publicado: (2019)

MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer
por: Jiao, Meng, et al.
Publicado: (2022)

Targeting the CCL2-CCR2 signaling axis in cancer metastasis
por: Lim, Su Yin, et al.
Publicado: (2016)

Murine Placental Erythroid Cells Are Mainly Represented by CD45(+) Immunosuppressive Erythroid Cells and Secrete CXCL1, CCL2, CCL3 and CCL4 Chemokines
por: Nazarov, Kirill, et al.
Publicado: (2023)

CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis
por: Yang, Hui, et al.
Publicado: (2020)

Mybl2 rejuvenates heart explant‐derived cells from aged donors after myocardial infarction
por: Rafatian, Ghazaleh, et al.
Publicado: (2020)

MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer
por: Li, Qiji, et al.
Publicado: (2021)

Purple Brassica oleracea var. capitata F. rubra is due to the loss of BoMYBL2–1 expression
por: Song, Hayoung, et al.
Publicado: (2018)

MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
por: Bayley, Rachel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_elenlqfs356hhcecpa60grjd7e